• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.载脂蛋白转化酶枯草溶菌素/ 克胰蛋白酶 9 基因 3’非翻译区多态性与 HIV/丙型肝炎病毒合并感染女性 HIV 病毒载量和 CD4+T 细胞水平的关系
AIDS. 2017 Nov 28;31(18):2483-2492. doi: 10.1097/QAD.0000000000001648.
2
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".尽管前蛋白转化酶枯草溶菌素9(PCSK9)水平较高,但HIV与丙型肝炎病毒合并感染的患者低密度脂蛋白胆固醇水平较低:一种明显的“PCSK9-脂质悖论”。
J Am Heart Assoc. 2016 Apr 29;5(5):e002683. doi: 10.1161/JAHA.115.002683.
3
Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.丙型肝炎病毒和前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9:增加病毒感染力和破坏脂质代谢的有害相互作用。
J Cell Mol Med. 2017 Dec;21(12):3150-3161. doi: 10.1111/jcmm.13273. Epub 2017 Jul 18.
4
Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.治疗诱导丙型肝炎病毒感染患者的病毒治愈涉及脂质平衡中三个重要分子参与者之间的动态相互作用:循环 microRNA(miR)-24、miR-223 和蛋白水解酶原转化酶枯草溶菌素/柯萨奇蛋白酶 9。
EBioMedicine. 2017 Sep;23:68-78. doi: 10.1016/j.ebiom.2017.08.020. Epub 2017 Aug 24.
5
Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters.抗逆转录病毒疗法对蛋白水解酶枯草溶菌素/克他命 9 的影响:重点关注脂质、炎症和免疫病毒学参数。
HIV Med. 2020 Sep;21(8):512-522. doi: 10.1111/hiv.12884. Epub 2020 Jun 4.
6
Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.基于多国 HIV 血清转换队列的丙型肝炎感染对 CD4+细胞计数和 HIV RNA 轨迹的影响。
AIDS. 2019 Feb 1;33(2):327-337. doi: 10.1097/QAD.0000000000002040.
7
HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.丙型肝炎病毒特异性产生白细胞介素-21的T细胞而非产生白细胞介素-17A的T细胞与HIV/HCV合并感染中的丙型肝炎病毒病毒控制相关。
PLoS One. 2016 Apr 28;11(4):e0154433. doi: 10.1371/journal.pone.0154433. eCollection 2016.
8
HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.在接受高效抗逆转录病毒治疗的 HIV/丙型肝炎病毒合并感染患者中,丙型肝炎病毒特异性 T 细胞应答与丙型肝炎病毒单感染个体中观察到的应答相当。
J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8. doi: 10.1097/qai.0b013e31821024e7.
9
Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.HIV/HCV 合并感染中的单核细胞活化与认知障碍相关。
PLoS One. 2013;8(2):e55776. doi: 10.1371/journal.pone.0055776. Epub 2013 Feb 21.
10
Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.在接受抗逆转录病毒治疗的 HIV/HCV 合并感染患者中,表型激活的 CD38(+) HLA-DR(+) CD8(+) T 细胞而非 CD38(+) HLA-DR(+) CD4(+) T 细胞明显富集。
J Med Virol. 2016 Aug;88(8):1347-56. doi: 10.1002/jmv.24475. Epub 2016 Jan 20.

引用本文的文献

1
Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection.前蛋白转化酶枯草溶菌素 9(PCSK9)抑制的潜在用途及病毒感染的预防方法。
Microb Cell Fact. 2024 Mar 25;23(1):90. doi: 10.1186/s12934-024-02355-8.
2
Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV.身体和性虐待的生活史与艾滋病毒感染者和非感染者的心血管疾病风险相关。
AIDS. 2024 Apr 1;38(5):739-750. doi: 10.1097/QAD.0000000000003822. Epub 2023 Dec 20.
3
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach.载脂蛋白 B100 代谢关键基因 LDLR 和 PCSK9 3´UTR 变异及其对家族性高胆固醇血症中 microRNA 分子相互作用的潜在影响:一种计算方法。
Mol Biol Rep. 2023 Nov;50(11):9165-9177. doi: 10.1007/s11033-023-08784-9. Epub 2023 Sep 30.
4
Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.HIV 感染的合并症:Nef 诱导的胆固醇代谢和脂筏功能障碍的作用。
AIDS. 2020 Jan 1;34(1):1-13. doi: 10.1097/QAD.0000000000002385.

本文引用的文献

1
PCSK9 and infection: A potentially useful or dangerous association?PCSK9 与感染:潜在有益还是危险的关联?
J Cell Physiol. 2018 Apr;233(4):2920-2927. doi: 10.1002/jcp.26040. Epub 2017 Jul 4.
2
Low LDL cholesterol, and genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.低密度脂蛋白胆固醇、基因变异与阿尔茨海默病和帕金森病风险:孟德尔随机化研究
BMJ. 2017 Apr 24;357:j1648. doi: 10.1136/bmj.j1648.
3
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.载脂蛋白 B 代谢关键基因 PCSK9 和 HMGCR 变异与心血管疾病和糖尿病风险
N Engl J Med. 2016 Dec 1;375(22):2144-2153. doi: 10.1056/NEJMoa1604304.
4
Human leucocyte antigen class I and II imputation in a multiracial population.多种族人群中人类白细胞抗原I类和II类的推算
Int J Immunogenet. 2016 Dec;43(6):369-375. doi: 10.1111/iji.12292. Epub 2016 Oct 24.
5
A review of PCSK9 inhibition and its effects beyond LDL receptors.PCSK9 抑制及其对 LDL 受体以外的影响的综述。
J Clin Lipidol. 2016 Sep-Oct;10(5):1073-80. doi: 10.1016/j.jacl.2016.07.004. Epub 2016 Jul 20.
6
Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.丙型肝炎病毒感染与HIV阳性女性CD4/CD8比值的关联
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):162-70. doi: 10.1097/QAI.0000000000000928.
7
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".尽管前蛋白转化酶枯草溶菌素9(PCSK9)水平较高,但HIV与丙型肝炎病毒合并感染的患者低密度脂蛋白胆固醇水平较低:一种明显的“PCSK9-脂质悖论”。
J Am Heart Assoc. 2016 Apr 29;5(5):e002683. doi: 10.1161/JAHA.115.002683.
8
New developments in proprotein convertase subtilisin-kexin 9's biology and clinical implications.前蛋白转化酶枯草杆菌蛋白酶/kexin 9的生物学新进展及其临床意义
Curr Opin Lipidol. 2016 Jun;27(3):274-81. doi: 10.1097/MOL.0000000000000295.
9
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.在丙型肝炎病毒患者中,阿托伐他汀和氟伐他汀与肝硬化和肝细胞癌的剂量依赖性降低相关:ERCHIVES研究结果。
Hepatology. 2016 Jul;64(1):47-57. doi: 10.1002/hep.28506. Epub 2016 Mar 25.
10
Metabolic alterations and hepatitis C: From bench to bedside.代谢改变与丙型肝炎:从实验室到临床
World J Gastroenterol. 2016 Jan 28;22(4):1461-76. doi: 10.3748/wjg.v22.i4.1461.

载脂蛋白转化酶枯草溶菌素/ 克胰蛋白酶 9 基因 3’非翻译区多态性与 HIV/丙型肝炎病毒合并感染女性 HIV 病毒载量和 CD4+T 细胞水平的关系

Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.

机构信息

aDepartment of Epidemiology and Biostatistics, University at Albany, State University of New York, Rensselaer, New York bDepartment of Statistics. George Washington University, Washington, DC cDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx dDepartment of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx eDepartment of Neurology, State University of New York Downstate Medical Center, Brooklyn, New York fDepartment of Medicine, Georgetown University Medical Center, Washington, DC gDepartment of Medicine, University of Southern California, Los Angeles, California hDepartment of Medicine, Rush University Medical Center, Chicago, Illinois iDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland jBluestone Center for Clinical Research kDepartment of Oral and Maxillofacial Surgery, New York University, New York, New York lDepartment of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, DC mDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

AIDS. 2017 Nov 28;31(18):2483-2492. doi: 10.1097/QAD.0000000000001648.

DOI:10.1097/QAD.0000000000001648
PMID:29120899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5724557/
Abstract

OBJECTIVE

To assess variation in genes that regulate cholesterol metabolism in relation to the natural history of HIV infection.

DESIGN

Cross-sectional and longitudinal analysis of the Women's Interagency HIV Study.

METHODS

We examined 2050 single nucleotide polymorphisms (SNPs) in 19 genes known to regulate cholesterol metabolism in relation to HIV viral load and CD4 T-cell levels in a multiracial cohort of 1066 antiretroviral therapy-naive women.

RESULTS

Six SNPs were associated with both HIV viral load and CD4 T-cell levels at a false discovery rate of 0.01. Bioinformatics tools did not predict functional activity for five SNPs, located in introns of nuclear receptor corepressor 2, retinoid X receptor alpha (RXRA), and tetratricopeptide repeat domain 39B. Rs17111557 located in the 3' untranslated region of proprotein convertase subtilisin/kexin type 9 (PCSK9) putatively affects binding of hsa-miR-548t-5p and hsa-miR-4796-3p, which could regulate PCSK9 expression levels. Interrogation of rs17111557 revealed stronger associations in the subset of women with HIV/hepatitis C virus (HCV) coinfection (n = 408, 38% of women). Rs17111557 was also associated with low-density lipoprotein cholesterol levels in HIV/HCV coinfected (β: -10.4; 95% confidence interval: -17.9, -2.9; P = 0.007), but not in HIV monoinfected (β:1.2; 95% confidence interval: -6.3, 8.6; P = 0.76) women in adjusted analysis.

CONCLUSION

PCSK9 polymorphism may affect HIV pathogenesis, particularly in HIV/HCV coinfected women. A likely mechanism for this effect is PCSK9-mediated regulation of cholesterol metabolism. Replication in independent cohorts is needed to clarify the generalizability of the observed associations.

摘要

目的

评估与 HIV 感染自然史相关的调节胆固醇代谢的基因变异。

设计

妇女艾滋病研究机构间的横断面和纵向分析。

方法

我们在一个由 1066 名未接受抗逆转录病毒治疗的妇女组成的多种族队列中,研究了与 HIV 病毒载量和 CD4 T 细胞水平相关的 19 个调节胆固醇代谢的基因中的 2050 个单核苷酸多态性(SNP)。

结果

在假发现率为 0.01 时,有 6 个 SNP 与 HIV 病毒载量和 CD4 T 细胞水平均相关。生物信息学工具并未预测位于核受体共抑制因子 2、视黄醇 X 受体α(RXRA)和四肽重复结构域 39B 内含子中的 5 个 SNP 的功能活性。位于前蛋白转化酶枯草杆菌蛋白酶/柯萨奇蛋白酶 9(PCSK9)3'非翻译区的 rs17111557 可能影响 hsa-miR-548t-5p 和 hsa-miR-4796-3p 的结合,从而调节 PCSK9 的表达水平。rs17111557 的检测结果显示,在 HIV/丙型肝炎病毒(HCV)合并感染的亚组妇女(n=408,占妇女的 38%)中,其相关性更强。rs17111557 还与 HIV/HCV 合并感染妇女的低密度脂蛋白胆固醇水平相关(β:-10.4;95%置信区间:-17.9,-2.9;P=0.007),但与 HIV 单感染妇女无关(β:1.2;95%置信区间:-6.3,8.6;P=0.76)。

结论

PCSK9 多态性可能影响 HIV 的发病机制,特别是在 HIV/HCV 合并感染的妇女中。这种影响的一个可能机制是 PCSK9 介导的胆固醇代谢调节。需要在独立的队列中进行复制,以阐明观察到的关联的普遍性。